Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
11/23/2011 | CN102256965A Pyrimidin-2-ylamino derivatives and their use to treat inflammation |
11/23/2011 | CN102256964A Compuestos inhibidores de quinasa map p38 |
11/23/2011 | CN102256963A Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd |
11/23/2011 | CN102256959A Novel thiophene compounds for use in theraphy |
11/23/2011 | CN102256952A Arylcyclopropylacetamide derivatives useful as glucokinase activators |
11/23/2011 | CN102256951A Certain crystalline hydrates,pharmaceutical compositions thereof and methods for preparation and use thereof |
11/23/2011 | CN102256948A Isoquinolinone derivatives as nk3 antagonists |
11/23/2011 | CN102256947A Substituted 4-(1,2,3,4-tetrahydroisochinolin-2-yl)-4-oxo-butyric acid amide as kcnq2/2 modulators |
11/23/2011 | CN102256943A Hemifumarate salt of 1- [4- [1- ( 4 -cyclohexyl-3 -trifluoromethyl-benzyloxyimino ) -ethyl] -2 -ethyl-benzyl] -a zetidine-3-carboxylic acid |
11/23/2011 | CN102256942A New polymorphic form of 1- (4- { l- [ (e) -4-cyclohexyl--3-trifluoromethyl-benzyloxyimino] -ethyl) -2-ethyl-benzy l) -azetidine-3-carboxylic |
11/23/2011 | CN102256941A New salts |
11/23/2011 | CN102256933A Organic compounds |
11/23/2011 | CN102256930A Polyunsaturated fatty acid and diol ester as an anti-acne agent |
11/23/2011 | CN102256635A Dry diazeniumdiolation methods for producing nitric oxide releasing medical devices |
11/23/2011 | CN102256616A Combination therapy with peptide epoxyketones |
11/23/2011 | CN102256607A Compositions and methods for treating matrix metalloproteinase 9 (mmp9)-mediated conditions |
11/23/2011 | CN102256606A Methods and means for efficient skipping of at least one of the following exons of the human duchenne muscular dystrophy gene: 43, 46, 50- 53. |
11/23/2011 | CN102256605A Pharmaceutical composition for prevention and treatment of diabetes or obesity comprising a compound that inhibits activity of dipeptidyl peptidase-iv, and other antidiabetic or antiobesity agents as active ingredients |
11/23/2011 | CN102256604A Aqueous oral preparation of stable amlodipine |
11/23/2011 | CN102256603A Inhibitors of mitosis for increasing apoptosis in therapy |
11/23/2011 | CN102256602A Composition for treatment of epithelial tissue |
11/23/2011 | CN102256596A Liposomal composition for convection-enhanced delivery to the central nervous centre |
11/23/2011 | CN102256594A Modulation of toll-like receptor 8 expression by antisense oligonucleotides |
11/23/2011 | CN102256502A Beer and beer-based beverages and method of modification of polyphenols and silicon content in these beverages |
11/23/2011 | CN102256494A Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2] oxaborol-1-ol |
11/23/2011 | CN102256493A Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities |
11/23/2011 | CN102256491A Isoxazole derivatives for use as fungicides |
11/23/2011 | CN102256488A Therapeutic compositions and methods for treating chronic kidney disease associated with a metabolic imbalance |
11/23/2011 | CN102251317A Preparation method of electrospun fibers with controllable drug release |
11/23/2011 | CN102250778A Lachnum sp., extracellular polysaccharide thereof and application of extracellular polysaccharide in lipid-lowering liver-favoring medicaments |
11/23/2011 | CN102250260A Enzyme engineering manufacturing method of functional glycan |
11/23/2011 | CN102250205A Preparation method of fatty acyl-RGD (Arg Gly Asp) induced docetaxel target liposome and antitumor activity thereof |
11/23/2011 | CN102250204A RGD sequence peptidyl methyl curcumin compounds, preparation method thereof, and application thereof |
11/23/2011 | CN102250203A Beta-carboline aminoacid benzyl ester, preparation method and application thereof |
11/23/2011 | CN102250197A Preparation method and application of total steroidal saponin extracts of dwarf lilyturf roots |
11/23/2011 | CN102250190A Oleanolic saponin derivative, preparation method of salt thereof and application of derivative |
11/23/2011 | CN102250189A Glycyrrhetic acid derivative with 1, 12-diene-3-ketone skeleton, its preparation method and medicinal uses |
11/23/2011 | CN102250186A Berberine-oryzanol compound, and preparation method and application thereof |
11/23/2011 | CN102250185A Glucocorticoid with NMDA ester positioned on site 21 |
11/23/2011 | CN102250182A Stigmaster-8(14)22,-diene-7alpha-methoxy-3beta-ol in cucumber roots and use thereof |
11/23/2011 | CN102250181A Polyhydroxy steroid compounds and purpose thereof |
11/23/2011 | CN102250179A Stable protein kinase activator, and preparation method and purpose thereof |
11/23/2011 | CN102250176A Antitumor antibiotic ancomycin and its derivative |
11/23/2011 | CN102250171A Rutin ester compound and its application in medicaments |
11/23/2011 | CN102250170A Preparation method and application of two active flavonoid glycosides in okra fruits |
11/23/2011 | CN102250168A 40H-GTS-21 compounds, preparation method and application thereof |
11/23/2011 | CN102250161A Irisone derivatives with tyrosinase inhibitory activity as well as preparation method and application thereof |
11/23/2011 | CN102250150A Organic hydridized tetra-core platinum complex and preparation method thereof as well as application technology field of complex in antitumor medicament preparation |
11/23/2011 | CN102250149A Ionic iridium coordination compounds having weak coordinate bonds and preparation method and use thereof |
11/23/2011 | CN102250144A Thiazolidone compound and application thereof |
11/23/2011 | CN102250143A Imidazole benzamide compounds and application thereof in preparation of anti-malignant tumor medicaments |
11/23/2011 | CN102250142A Andrographolide compound and application of andrographolide compound in medicaments |
11/23/2011 | CN102250138A Germatrane compound as well as preparation method and application thereof |
11/23/2011 | CN102250127A Tetrahydro carboline derivative modified with two amino acids and preparation method and application thereof |
11/23/2011 | CN102250123A Cefodizime sodium hydrate as well as preparation method and application thereof |
11/23/2011 | CN102250109A Phenol compounds as well as preparation method and application thereof |
11/23/2011 | CN102250106A Extraction method of sesquiterpene lactone compound from Chinese mugwort leaf and application thereof |
11/23/2011 | CN102250105A Camptothecin derivatives, synthesis method thereof and use thereof |
11/23/2011 | CN102250104A Camptothecin derivative, and its synthetic method and application |
11/23/2011 | CN102250100A Indolactam alkaloid and use of indolactam alkaloid in preparation of antimalarial drugs |
11/23/2011 | CN102250099A Non-peptide thrombin inhibitors as well as preparation method and medical application thereof |
11/23/2011 | CN102250098A Pyrazinones compound |
11/23/2011 | CN102250095A Carbapenem derivative or hydrate crystal and preparation method thereof |
11/23/2011 | CN102250094A 2-alkylthio-9-alcoxyalkyl adenine compound and synthesis thereof |
11/23/2011 | CN102250089A Beta-carboline alkaloid and application thereof to preparing antimalarial medicaments |
11/23/2011 | CN102250087A Use of several tetrahydro-proto-berberine compounds in relief of pain |
11/23/2011 | CN102250085A Bifendate derivative and use thereof in preparation of drugs for treating autoimmune diseases |
11/23/2011 | CN102250084A Dasatinib polymorphic substance as well as preparation method and pharmaceutical composition thereof |
11/23/2011 | CN102250075A 2,4-disubstituted quinazoline compounds and preparation method, medicinal composition and application thereof |
11/23/2011 | CN102250074A Thiophene analogues for treatment or prevention of flavivirus infections |
11/23/2011 | CN102250071A Pyrazole compounds useful as protein kinase inhibitors |
11/23/2011 | CN102250069A Pyrrolic amide compound and purpose thereof in preparation of anti-malignant tumor medicament |
11/23/2011 | CN102250066A Fasudil derivative and preparation method thereof |
11/23/2011 | CN102250065A Substituted triazine phenyl urea derivatives and application thereof |
11/23/2011 | CN102250064A Glutamic acid derivants |
11/23/2011 | CN102250061A Pyrimidine benzamide compound and application in preparing drugs for resisting malignant tumors thereof |
11/23/2011 | CN102250053A Selective norepinephrine reuptake inhibitor and purpose thereof in preparation of medicament for attention deficit / hyperactivity disorder |
11/23/2011 | CN102250048A 2-phenylselenomethyl-2,3-dihydrobenzofuran and preparation and application thereof |
11/23/2011 | CN102250047A More-stable taxol compound and medicament composition thereof |
11/23/2011 | CN102250045A Mycobacterium tuberculosis resisting compounds, and applications thereof |
11/23/2011 | CN102250042A Selective estrogen receptor modulators for the treatment of vasomotor symptoms |
11/23/2011 | CN102250035A Synthesis method and medicinal purpose of diaryl substituted-1,3,4-oxadiazole compounds |
11/23/2011 | CN102250031A High-purity valsartan compound |
11/23/2011 | CN102250022A Substituted quinoxalinamine compounds, and preparation method and application thereof |
11/23/2011 | CN102250019A (Thio) barbituric acid compound and application thereof |
11/23/2011 | CN102250006A 3-pyrazole carboxylic acid amide compounds, preparation method thereof and application thereof in preparation of medicament serving as CB1 receptor inhibitor |
11/23/2011 | CN102250003A Sinomenine sulfonic acid compound and its preparation and application |
11/23/2011 | CN102250000A Indenoquinolinone compounds, and preparation method and application thereof |
11/23/2011 | CN102249987A Combretastatin compound and preparation method and application thereof |
11/23/2011 | CN102249982A Novel pleuromutilin compound, and medical composition, preparation method and application thereof |
11/23/2011 | CN102249981A N-arylsulfonyl-3-aminoalkoxyindoles |
11/23/2011 | CN102249978A KY crystal form of Atorvastatin calcium and preparation method thereof |
11/23/2011 | CN102249975A (S)-4-hydroxy-2-oxo-1-pyrrolidineacetamide crystal form I and preparation method and application thereof |
11/23/2011 | CN102249969A Phenyl-(3-aryl-2-allyl)selenide compounds, and preparation method and application thereof |
11/23/2011 | CN102249958A Inhibitor of benzoylammonia histone deacetylase |
11/23/2011 | CN102249951A Aminophenyl ketone compound and application thereof in preparing antipsychotic drugs |
11/23/2011 | CN102249945A Salicyloyl anilines compound as well as preparation method and application thereof |
11/23/2011 | CN102249936A Hydrate of O-desmethylvenlafaxine hydrochloride and preparation method thereof |
11/23/2011 | CN102249935A Aromatic 2-butanols compound and medical application thereof |
11/23/2011 | CN102249917A Chicoric acid and extraction and separation method and application thereof |